文献速递肾移植肾小球疾病

局灶节段性肾小球硬化受者肾移植的长期结局

Long-Term Outcome of Kidney Transplantation in Recipients with Focal Segmental Glomerulosclerosis.
PubMed 文献 · Clin J Am Soc Nephrol · 2016-10-20

基于澳大利亚和新西兰透析与移植登记库,评估1992至2011年736例活检证实的原发性FSGS首次肾移植受者。FSGS复发76例(10.3%);活体供肾复发更多,但活体供肾移植的移植物存活仍显著优于尸体供肾;复发者5年移植物存活52%,无复发者83%。作者提出不应回避活体供肾移植。

要点

  • FSGS移植后复发率为10.3%(76/736)。
  • 年轻、非白人种族和活体供肾是复发的独立危险因素。
  • 活体供肾移植物中位存活14.8年,优于尸体供肾的12.1年。

核心结论

  • FSGS肾移植后复发在活体供肾中更常见,但活体供肾受者的移植物存活在儿童和成人中均显著更优。
  • 作者提出,FSGS患者不应避免活体供肾移植。

研究设计与样本

  • 利用澳大利亚和新西兰透析与移植登记库,采用Kaplan-Meier和逻辑回归分析,评估活检证实的原发性FSGS所致终末期肾病受者的FSGS复发发生率、供肾类型对复发风险的影响及移植物丢失。
  • 1992年至2011年间,共736例首次肾移植,包括666名成人和70名儿童(≤20岁)。

主要发现

  • 76例(10.3%)患者FSGS复发。
  • 年轻年龄(P<0.001)、非白人种族(P=0.02)和活体供肾(P=0.02)是与复发相关的独立危险因素。
  • 活体供肾移植物中位存活14.8年,优于尸体供肾的12.1年(P<0.01)。
  • 复发组5年移植物存活52%(95%CI 40%至63%),无复发组83%(95%CI 79%至86%)(P<0.001)。

临床怎么用

  • 作者提出,FSGS患者不应避免活体供肾移植。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: FSGS can recur after kidney transplantation and is associated with poor graft outcomes. We aimed to assess the incidence of FSGS recurrence post-transplant and determine the effect of graft source on recurrence and graft survival in patients with biopsy-proven FSGS. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Using the Australian and New Zealand Dialysis and Transplant Registry, we assessed incidence of FSGS, the influence of donor type on the risk of FSGS recurrence, and graft loss in recipients with ESRD caused by primary FSGS using Kaplan-Meier and logistic regression analyses. RESULTS: Between 1992 and 2011, 736 first kidney transplants were performed in 666 adults and 70 children (≤20 years old) with biopsy-proven primary FSGS. FSGS recurred in 76 (10.3%) patients. Younger age (P<0.001), nonwhite ethnicity (P=0.02), and having a live donor (P=0.02) were independent risk factors associated with recurrence. Median graft survival was significantly better for live donor compared with deceased donor grafts (14.8 versus 12.1 years; P<0.01). Disease recurrence predicted poor graft outcomes, with 52% (95% confidence interval, 40% to 63%) 5-year graft survival in the recurrence group compared with 83% (95% confidence interval, 79% to 86%) in the group without recurrent disease (P<0.001). CONCLUSIONS: FSGS recurrence after kidney transplantation was more common in live donor kidneys. Despite this, graft survival in live donor recipients was significantly better for both children and adults with FSGS. We propose that live donor transplantation should not be avoided in patients with FSGS.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Francis A, Trnka P, McTaggart SJ, et al. Long-Term Outcome of Kidney Transplantation in Recipients with Focal Segmental Glomerulosclerosis. Clin J Am Soc Nephrol. 2016. PMID: 27797890. doi:10.2215/CJN.03060316

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。